Market Overview:
Microfluidic device system market is expected to register a CAGR of 10.8% during the forecast period 2018-2030. The global microfluidic device system market is segmented on the basis of type, application and region. On the basis of type, the global microfluidic device system market is segmented into glass, polymer and silicon. Glass dominates the global microfluidic device system market in terms of revenue share in 2017 and is expected to maintain its dominance throughout the forecast period 2018-2030. Polymer based microfluidics devices are witnessing high adoption due to their low cost as compared to glass or silicon based devices.
Product Definition:
A microfluidic device system is a collection of interconnected microfluidic devices that can be used to manipulate and analyze fluids on a small scale. The importance of microfluidic device systems lies in their ability to enable the study and manipulation of fluids at the molecular level, which can lead to advances in areas such as drug discovery and diagnostics.
Glass:
Glass is a transparent, brittle, non-reactive material that can be used in microfluidic device system. It has wide range of applications such as it can be used for storing liquids and gases. Glass also provides robust barrier to chemicals and water vapor inside the sealed container.
Polymer:
Polymer is a substance that can be made up of molecules composed of multiple elements connected by bonds. There are two types of polymers, natural and synthetic. Natural polymers are derived from sources such as plants, animals, bacteria and viruses; while synthetic ones are manufactured in laboratories for various applications.
Application Insights:
The point of care testing application segment dominated the global market in terms of revenue in 2017. This is attributed to the growing demand for point of care diagnostic devices that are used for medical diagnosis at the scene of an emergency or a hospital. The rapid response time and ease with which these devices can be deployed are some factors that have contributed to their increasing adoption across various end-use applications.
Microfluidic device systems find wide applications in drug delivery, environmental monitoring, clinical diagnostics, and life science research among others. Some key application areas include drug delivery, environmental monitoring, clinical diagnostics and life science research among others involving molecular biology techniques such as DNA/RNA amplification & detection methods along with protein purification & detection methods using microfluidic device systems as lab-on-chip platforms offer numerous advantages including miniaturization; increased efficiency; cost reduction; higher specificity; shorter preparation time required.; improved portability due to smaller size.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of a large number of microfluidic device manufacturers and suppliers. The region is expected to maintain its dominance over the forecast period due to continuous innovations and technological advancements in research tools. Moreover, increasing investments by pharmaceutical companies for drug discovery are anticipated to drive regional growth.
Asia Pacific is projected to grow at a lucrative rate during the forecast period owing to untapped opportunities, constantly improving healthcare infrastructure, rising patient awareness levels coupled with economic development in emerging countries such as China & India and Japan. These factors are expected contribute toward regional growth during the forecast period from 2018-2030 and beyond in several areas including point of care testing; diagnostic devices; environmental monitoring applications; clinical diagnostics; pharmaceuticals & life science research.; animal health diagnostics).
Growth Factors:
- Increasing demand for miniaturization in the medical device industry
- Rising prevalence of chronic diseases that require point-of-care testing
- Technological advancements in microfluidic devices
- Growing number of private and public sector funding initiatives for microfluidics research
- Proliferation of start-ups focused on developing novel microfluidic devices
Scope Of The Report
Report Attributes
Report Details
Report Title
Microfluidic Device System Market Research Report
By Type
Glass, Polymer, Silicon
By Application
Point of Care Testing, Pharmaceutical and Life Science Research, Drug Delivery, Analytical Devices, Clinical and Veterinary Diagnostics, Environment and Industrial
By Companies
Roche Diagnostics, Abbott Laboratories, Siemens Healthcare, Agilent Technologies, Fluidigm, Bio- Rad Laboratories, Cepheid, RainDance Technologies, Dolomite Centre, Micronit Microfluidics, Roche Diagnostics, Becton, Dickinson and Company
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
236
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Microfluidic Device System Market Report Segments:
The global Microfluidic Device System market is segmented on the basis of:
Types
Glass, Polymer, Silicon
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Point of Care Testing, Pharmaceutical and Life Science Research, Drug Delivery, Analytical Devices, Clinical and Veterinary Diagnostics, Environment and Industrial
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Roche Diagnostics
- Abbott Laboratories
- Siemens Healthcare
- Agilent Technologies
- Fluidigm
- Bio- Rad Laboratories
- Cepheid
- RainDance Technologies
- Dolomite Centre
- Micronit Microfluidics
- Roche Diagnostics
- Becton, Dickinson and Company
Highlights of The Microfluidic Device System Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Glass
- Polymer
- Silicon
- By Application:
- Point of Care Testing
- Pharmaceutical and Life Science Research
- Drug Delivery
- Analytical Devices
- Clinical and Veterinary Diagnostics
- Environment and Industrial
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Microfluidic Device System Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A microfluidic device system is a collection of interconnected microchannels and devices that can be used to carry out specific tasks. These systems are often used in research and development, as they allow for the controlled manipulation of small quantities of fluid.
Some of the key players operating in the microfluidic device system market are Roche Diagnostics, Abbott Laboratories, Siemens Healthcare, Agilent Technologies, Fluidigm, Bio- Rad Laboratories, Cepheid, RainDance Technologies, Dolomite Centre, Micronit Microfluidics, Roche Diagnostics, Becton, Dickinson and Company.
The microfluidic device system market is expected to register a CAGR of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Microfluidic Device System Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Microfluidic Device System Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Microfluidic Device System Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Microfluidic Device System Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Microfluidic Device System Market Size & Forecast, 2020-2028
4.5.1 Microfluidic Device System Market Size and Y-o-Y Growth
4.5.2 Microfluidic Device System Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Glass
5.2.2 Polymer
5.2.3 Silicon
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Point of Care Testing
6.2.2 Pharmaceutical and Life Science Research
6.2.3 Drug Delivery
6.2.4 Analytical Devices
6.2.5 Clinical and Veterinary Diagnostics
6.2.6 Environment and Industrial
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Microfluidic Device System Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Microfluidic Device System Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Glass
9.6.2 Polymer
9.6.3 Silicon
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Point of Care Testing
9.10.2 Pharmaceutical and Life Science Research
9.10.3 Drug Delivery
9.10.4 Analytical Devices
9.10.5 Clinical and Veterinary Diagnostics
9.10.6 Environment and Industrial
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Glass
10.6.2 Polymer
10.6.3 Silicon
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Point of Care Testing
10.10.2 Pharmaceutical and Life Science Research
10.10.3 Drug Delivery
10.10.4 Analytical Devices
10.10.5 Clinical and Veterinary Diagnostics
10.10.6 Environment and Industrial
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Glass
11.6.2 Polymer
11.6.3 Silicon
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Point of Care Testing
11.10.2 Pharmaceutical and Life Science Research
11.10.3 Drug Delivery
11.10.4 Analytical Devices
11.10.5 Clinical and Veterinary Diagnostics
11.10.6 Environment and Industrial
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Glass
12.6.2 Polymer
12.6.3 Silicon
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Point of Care Testing
12.10.2 Pharmaceutical and Life Science Research
12.10.3 Drug Delivery
12.10.4 Analytical Devices
12.10.5 Clinical and Veterinary Diagnostics
12.10.6 Environment and Industrial
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Glass
13.6.2 Polymer
13.6.3 Silicon
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Point of Care Testing
13.10.2 Pharmaceutical and Life Science Research
13.10.3 Drug Delivery
13.10.4 Analytical Devices
13.10.5 Clinical and Veterinary Diagnostics
13.10.6 Environment and Industrial
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Microfluidic Device System Market: Competitive Dashboard
14.2 Global Microfluidic Device System Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Roche Diagnostics
14.3.2 Abbott Laboratories
14.3.3 Siemens Healthcare
14.3.4 Agilent Technologies
14.3.5 Fluidigm
14.3.6 Bio- Rad Laboratories
14.3.7 Cepheid
14.3.8 RainDance Technologies
14.3.9 Dolomite Centre
14.3.10 Micronit Microfluidics
14.3.11 Roche Diagnostics
14.3.12 Becton, Dickinson and Company
